Clinical Trials

Overview

About this study

The purpose of this study is to analyze clinical, radiological, and genotypic data of a cohort of 384 patients with cystic kidney disease who underwent Renasight (Natera) genetic testing at Mayo Clinic (dataset will consist of patients from IRB# 13-003971 who consented have their information/samples stored and used in future research at Mayo Clinic or patients that participated in a previous study of the RenaCARE application (21-02744) and who orally consent to participate in this research (203), and those who had clinical testing with Renasight at Mayo Rochester (203) and Jacksonville (118)).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Participating Mayo Clinic locations

More information